Table 1 Clinical characteristics of 112 CKD patients.

Males/females (no.)

59/53

Age (years)

63.6 ± 14.0

f(HNA) (%)

30.0 ± 6.1

Body mass index (kg/m²)

22.5 ± 4.4

eGFR (mL/min/1.73 m²)

30.7 ± 15.6

Creatinine (mg/dL)

2.2 ± 1.4

Blood urea nitrogen (mg/dL)

33 ± 20

Aspartate transaminase (IU/L)

20 ± 6.7

Alanine transaminase (IU/L)

16 ± 9.4

Total protein (g/dL)

6.9 ± 0.7

Albumin (g/dL)

3.8 ± 0.5

C-reactive protein (mg/dL)

0.23 ± 0.4

Uric acid (mg/dL)

6.5 ± 1.5

Hemoglobin (g/dL)

12.5 ± 1.6

Ferritin (ng/mL)

105 ± 105

Transferrin saturation (%)

27 ± 11

Plasma glucose (mg/dL)

105 ± 32

Hemoglobin A1c (%)

5.7 ± 0.6

Sodium (mEq/L)

141 ± 2.5

Potassium (mEq/L)

4.5 ± 0.5

Chloride (mEq/L)

107 ± 3.3

Sodium-chloride (mEq/L)

33.7 ± 2.9

Corrected calcium (mg/dL)

9.4 ± 0.7

Phosphate (mg/dL)

3.9 ± 0.8

Intact-PTH (pg/mL)

104 ± 106

Fibroblast growth factor-23 (pg/mL)

116 ± 1106

1,25-dihydroxyvitamin D (pg/mL)

38.4 ± 16.2

Urinary protein (g/gCr)

2.3 ± 1.9

ESA user/non-user

26/86

Iron supplementation, yes/no

18/94

ARB, yes/no

67/45

ACEI, yes/no

1/111

Calcium antagonist, yes/no

56/56

Active vitamin D, yes/no

27/85

Phosphate binders, yes/no

9/103

AST-120, yes/no

9/103